Review
doi: 10.1038/ejhg.2008.10. Epub 2008 Feb 20.Smith-Lemli-Opitz syndrome: pathogenesis, diagnosis and management
Affiliations
- PMID:18285838
- DOI: 10.1038/ejhg.2008.10
Item in Clipboard
Review
Smith-Lemli-Opitz syndrome: pathogenesis, diagnosis and management
Forbes D Porter. Eur J Hum Genet.2008 May.
Display options
Format
Display options
Format
Abstract
Smith-Lemli-Opitz syndrome (SLOS) is a malformation syndrome due to a deficiency of 7-dehydrocholesterol reductase (DHCR7). DHCR7 primarily catalyzes the reduction of 7-dehydrocholesterol (7DHC) to cholesterol. In SLOS, this results in decreased cholesterol and increased 7DHC levels, both during embryonic development and after birth. The malformations found in SLOS may result from decreased cholesterol, increased 7DHC or a combination of these two factors. This review discusses the clinical aspects and diagnosis of SLOS, therapeutic interventions and the current understanding of pathophysiological processes involved in SLOS.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous